Old API Wind-down Ltd - Ordinary Shares ARLZQ

Question for Y'all

[goldbug83]

Do any of you recall a NR or conference call where Adams or anyone else mentioned ARLZ applying to have Yosprala sold OTC? If this really is the "gold standard" of daily Asprin use why not get it into the hands of as many customers as possible even if it's at a lower price point than the prescription model.

[CHECKMATE77]

Far better to start with directed demand, ie rx status in one word Insurance on rx the drug will be paid by insurance,  after a few years , onceit is well known and growth has stalled then go otc cm

[mjh9413]

I think you hit it on the head as the survey of existing MD's who prescribe aspirin for continuing care supposedly gave rise to that 39% market share number, those who would/might scrip ARZ's product. I can hardly imagine it as an OTC product given the label warning requirements, some of which I must say were a surprise at this stage. 

[goldbug83]

I think it really depends on their price point. A lot of medical plans cover around 50% to 80% for prescription drugs. Have you ever taken a look at the price of generic Asprin at say Walmart? It's dirt cheap. Check this price out here Bayer, a name brand, sells 300 low dose daily tablets for $11.98US regualr price, that's under $0.04 per tablet. Even with the coverage of medical plans

[CHECKMATE77]

As a rx drug you have to convince md that the medication had efficacy, this is done with visits, conferences, and journal ads. as an otc, you have to convince the consumer ( very hard) or pharmacists to recommend the medication. many family md wait until the specialists use a new medication, then they adopt it. i have seen this scenario play out numerous times in the pharmacy world rx then otc the